Update on myocarditis – review (RCD code: III-6A.1)

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 1, Issue 6

Abstract

Myocardits is an inflammatory disease of the myocardium diagnosed by established histological and immunohistochemical criteria. The true incidence of myocarditis is unknown. There are numerous potential etiologic factors, however, in developed countries the most frequent cause of myocarditis are viral infections. The pathogenesis of viral myocarditis and subsequent dilated cardiomyopathy (DCM) is not fully understood and differ between viruses. The progression of acute cardiac inflammation to DCM is the three-phase process, including viral (cytopathic), (auto)-immunulogic, and recovery or myopathic phase. Cardiac symptoms are variable and include reduced functional capacity due to dyspnoe and/or fatigue, palpitations, precordial chest pain which result from associated pericarditis or coronary artery spasms.Diagnostic work-up in myocarditis is multistage and requires integration of clinical symptoms, laboratory and imaging data, all of which have an adjunctive role to the endomyocardial biopsy (EMB), which is final and ultimately decisive diagnostic tool. All patients with clinically suspected myocarditis should undergo detailed echocardiographic examination to rule out other cardiac diseases and to assess and monitor changes in chamber size, wall thickness, ventricular systolic and diastolic function, or pericardial effusions. Nevertheless, cardiac magnetic resonance is superior to echocardiography in terms of non-invasive tissue characterization. Recent trails have provided substantial body of evidence for additional myocarditis-specific or tailored therapies, including anti-viral and immuno-modulating therapy such as high dose intravenous immunoglobulin, immunoadsorption, and immunosuppression. JRCD 2014; 1 (6): 4–9

Authors and Affiliations

Pawel Rubis, Piotr Podolec

Keywords

Related Articles

Blood cyst attached to the anterior leaflet of the mitral valve. (RCD code: VI-1A.0)

We report a case of a 15 year old boy with a cyst attached to the anterior leaflet of mitral valve. At the age of 6 he was submitted for a cardiac evaluation due to a heart murmur. On physical exam a soft systolic murmur...

Classification of Rare Cardiovascular Diseases (RCD Classification), Krakow 2013

Almost every day brings new reports of a “rare” (“orphan”) disease – a disease that requires multidisciplinary knowledge and particular caution in making diagnostic and therapeutic decisions.The Classification of Rare Ca...

Comparison of platelet count reduction in patients with essential thrombocythaemia treated with hydroxyurea and thromboreductin. Single centre experience

Essential thrombocythemia is one of the Ph-negative myeloproliferative neoplasms treated with hydroxyurea. An alternative strategy may be a therapy with thromboreductin. The aim of the study was to compare the effectiven...

Patient with constrictive pericarditis (RCD code: III)

52-year-old Caucasian man was admitted with clinical symptoms of chronic heart failure. Constrictive pericarditis was suspected almost 9 years before admission, but Patient refused to diagnosis. Peripheral oedema, ascite...

Pregnancy and congenital complete atrioventricular block: management during pregnancy and the periparturient period

Complete atrioventricular block (AVB) is rare during pregnancy. Congenital atrioventricular block is the most common type of heart block in this group of patients. About one‐third of female patients with complete AVB re...

Download PDF file
  • EP ID EP245434
  • DOI 10.20418/jrcd.vol1no6.118
  • Views 121
  • Downloads 0

How To Cite

Pawel Rubis, Piotr Podolec (2014). Update on myocarditis – review (RCD code: III-6A.1). Journal of Rare Cardiovascular Diseases, 1(6), 4-9. https://europub.co.uk/articles/-A-245434